BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 12351408)

  • 1. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment.
    Daskalakis M; Nguyen TT; Nguyen C; Guldberg P; Köhler G; Wijermans P; Jones PA; Lübbert M
    Blood; 2002 Oct; 100(8):2957-64. PubMed ID: 12351408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [p15(INK4B) methylation on prognosis and response to decitabine in patients with MDS].
    Zhang Y; Song LX; Wu LY; Chang CK; Li X
    Zhonghua Xue Ye Xue Za Zhi; 2013 Mar; 34(3):237-41. PubMed ID: 23683424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.
    Lindsey JC; Lusher ME; Anderton JA; Bailey S; Gilbertson RJ; Pearson AD; Ellison DW; Clifford SC
    Carcinogenesis; 2004 May; 25(5):661-8. PubMed ID: 14688019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Abnormality of p15(INK4b) gene and myelodysplastic syndrome].
    Wang Z; Li YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Aug; 10(4):362-5. PubMed ID: 12513775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of the p15(INK4B) gene in acute leukemia and myelodysplastic syndromes.
    Chen H; Wu S
    Chin Med J (Engl); 2002 Jul; 115(7):987-90. PubMed ID: 12150726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of HO-1 promoted apoptosis induced by decitabine via increasing p15INK4B promoter demethylation in myelodysplastic syndrome.
    Ma D; Fang Q; Wang P; Gao R; Sun J; Li Y; Hu XY; Wang JS
    Gene Ther; 2015 Apr; 22(4):287-96. PubMed ID: 25652099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studies.
    Hackanson B; Robbel C; Wijermans P; Lübbert M
    Ann Hematol; 2005 Dec; 84 Suppl 1():32-8. PubMed ID: 16292549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression.
    Quesnel B; Guillerm G; Vereecque R; Wattel E; Preudhomme C; Bauters F; Vanrumbeke M; Fenaux P
    Blood; 1998 Apr; 91(8):2985-90. PubMed ID: 9531610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of the p15(INK4B) gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation.
    Tien HF; Tang JH; Tsay W; Liu MC; Lee FY; Wang CH; Chen YC; Shen MC
    Br J Haematol; 2001 Jan; 112(1):148-54. PubMed ID: 11167795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
    Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
    J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P15INK4b gene methylation and myelodysplastic syndromes.
    Quesnel B; Fenaux P
    Leuk Lymphoma; 1999 Nov; 35(5-6):437-43. PubMed ID: 10609781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome.
    Hofmann WK; Takeuchi S; Takeuchi N; Thiel E; Hoelzer D; Koeffler HP
    Leuk Res; 2006 Nov; 30(11):1347-53. PubMed ID: 16682076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The re-expression of p15(INK4B) gene in leukemia cells induced by in vitro DNA methyltransferase and histone deacetylase inhibition].
    Ren L; Du H; Zhu Q; Shi Y; Chen H; Wu S
    Zhonghua Nei Ke Za Zhi; 2002 Nov; 41(11):762-5. PubMed ID: 12485524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia.
    Christiansen DH; Andersen MK; Pedersen-Bjergaard J
    Leukemia; 2003 Sep; 17(9):1813-9. PubMed ID: 12970781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome of treatment with a combined regimen of decitabine and aclacinomycin/cytarabine for patients with refractory acute myeloid leukemia.
    Song LX; Xu L; Li X; Chang CK; Zhang Y; Wu LY; He Q; Zhang QX; Li X
    Ann Hematol; 2012 Dec; 91(12):1879-86. PubMed ID: 22895556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene silencing of the p15/INK4B cell-cycle inhibitor by hypermethylation: an early or later epigenetic alteration in myelodysplastic syndromes?
    Lübbert M
    Leukemia; 2003 Sep; 17(9):1762-4. PubMed ID: 12970776
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of heme oxygenase-1 in demethylating effects on SKM-1 cells induced by decitabine.
    Gao R; Ma D; Wang P; Sun J; Wang JS; Fang Q
    Genet Mol Res; 2015 Dec; 14(4):17788-98. PubMed ID: 26782424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation status of the p15 and p16 genes in paediatric myelodysplastic syndrome and juvenile myelomonocytic leukaemia.
    Hasegawa D; Manabe A; Kubota T; Kawasaki H; Hirose I; Ohtsuka Y; Tsuruta T; Ebihara Y; Goto Y; Zhao XY; Sakashita K; Koike K; Isomura M; Kojima S; Hoshika A; Tsuji K; Nakahata T
    Br J Haematol; 2005 Mar; 128(6):805-12. PubMed ID: 15755284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies.
    Issa JP; Garcia-Manero G; Giles FJ; Mannari R; Thomas D; Faderl S; Bayar E; Lyons J; Rosenfeld CS; Cortes J; Kantarjian HM
    Blood; 2004 Mar; 103(5):1635-40. PubMed ID: 14604977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress levels are correlated with P15 and P16 gene promoter methylation in myelodysplastic syndrome patients.
    Gonçalves AC; Cortesão E; Oliveiros B; Alves V; Espadana AI; Rito L; Magalhães E; Pereira S; Pereira A; Costa JM; Mota-Vieira L; Sarmento-Ribeiro AB
    Clin Exp Med; 2016 Aug; 16(3):333-43. PubMed ID: 25982567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.